Skip Navigation

A Phase II, Open-Label, Multicenter Study of INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.

Brief Summary

Head and Neck Cancers

Study Type:

II Identifier:

Study #:

Start Date:
Feb 23, 2023

Full Details and Eligibility at

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below. ID: NCT05359692

View Complete Trial Details & Eligibility at